Novonesis (Novozymes) B
NSISBC
Rank in Stocks
#1160
Established in January 2024 through the amalgamation of Novozymes A/S and Chr.... Established in January 2024 through the amalgamation of Novozymes A/S and Chr. Hansen, Novonesis now stands as a prominent global leader in biosolutions. The firm's activities encompass the worldwide development and commercialization of industrial enzymes, diverse microorganisms, and vital biopharmaceutical ingredients. Distinctively, its Class B shares are listed independently and actively traded on various European exchanges.
Share Price
$70.10
Last synced: 2026-10-21
Market Cap
$19.48B
Change (1 day)
-4.64%
Change (1 year)
10.57%
Country
DK
Trade Novonesis (Novozymes) B (NSISBC)
Category
Basic Materials
Number of shares outstanding for Novonesis (Novozymes) B (NSISBC)
Number of shares outstanding as of October 2026: 0
According to Novonesis (Novozymes) B latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of October 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Novonesis (Novozymes) B (NSISBC) from 2026 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| Not enough data for the provided dates. | ||
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| 462.53M | - |
GB
|
|
| - | - |
FR
|
|
| 244.80M | - |
US
|
|
| 281.30M | - |
US
|
|
| 222.80M | - |
US
|
